Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Opioid Requirements With Scheduled Intranasal Ketamine During Admission for Traumatic Pain

NCT05671913 is registered in ClinicalTrials.gov with Sanford Health as lead sponsor.

NCT NCT05671913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05671913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Opioid Requirements With Scheduled Intranasal Ketamine During Admission for Traumatic Pain
Lead sponsor
Sanford Health
Phase
Phase 1
Overall status
Withdrawn
Start date
January 1, 2023
Completion date
January 1, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain, trauma